<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15</volume><submitter>Phetkong C</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Hepatocellular carcinoma (HCC) remains a major cause of cancer mortality, and effective therapeutic options are limited. MicroRNA‑372‑3p (miR‑372‑3p) has been implicated in HCC, yet its exact role is unclear.&lt;h4>Methods&lt;/h4>We established miR‑372‑3p‑overexpressing HCC cell lines (HepG2, SNU‑449, JHH‑4) via lentiviral transduction. Malignant phenotypes were assessed with MTT, transwell migration/invasion, and colony‑formation assays. Transcriptomic changes were analyzed by RNA‑sequencing followed by Gene Set Enrichment Analysis. Lipid metabolism was examined using BODIPY/Oil Red O staining, triglyceride quantification, FAOBlue assays, and organelle colocalization imaging. Candidate targets of miR‑372‑3p were computationally predicted and validated by dual‑luciferase rep</pubmed_abstract><journal>BioImpacts : BI</journal><pagination>31075</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12413982</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>MicroRNA-372-3p impairs fatty acid metabolism in hepatocellular carcinoma cells by targeting &amp;lt;i&amp;gt;CPT1A&amp;lt;/i&amp;gt; and &amp;lt;i&amp;gt;ACSL4&amp;lt;/i&amp;gt;.</pubmed_title><pmcid>PMC12413982</pmcid><pubmed_authors>Boonto T</pubmed_authors><pubmed_authors>Phetkong C</pubmed_authors><pubmed_authors>Thamjamrassri P</pubmed_authors><pubmed_authors>Tangkijvanich P</pubmed_authors><pubmed_authors>Ariyachet C</pubmed_authors></additional><is_claimable>false</is_claimable><name>MicroRNA-372-3p impairs fatty acid metabolism in hepatocellular carcinoma cells by targeting &amp;lt;i&amp;gt;CPT1A&amp;lt;/i&amp;gt; and &amp;lt;i&amp;gt;ACSL4&amp;lt;/i&amp;gt;.</name><description>&lt;h4>Introduction&lt;/h4>Hepatocellular carcinoma (HCC) remains a major cause of cancer mortality, and effective therapeutic options are limited. MicroRNA‑372‑3p (miR‑372‑3p) has been implicated in HCC, yet its exact role is unclear.&lt;h4>Methods&lt;/h4>We established miR‑372‑3p‑overexpressing HCC cell lines (HepG2, SNU‑449, JHH‑4) via lentiviral transduction. Malignant phenotypes were assessed with MTT, transwell migration/invasion, and colony‑formation assays. Transcriptomic changes were analyzed by RNA‑sequencing followed by Gene Set Enrichment Analysis. Lipid metabolism was examined using BODIPY/Oil Red O staining, triglyceride quantification, FAOBlue assays, and organelle colocalization imaging. Candidate targets of miR‑372‑3p were computationally predicted and validated by dual‑luciferase rep</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-02T22:37:03.656Z</modification><creation>2026-05-28T03:07:00.328Z</creation></dates><accession>S-EPMC12413982</accession><cross_references><pubmed>40922951</pubmed><doi>10.34172/bi.31075</doi></cross_references></HashMap>